Terbinafine Hydrochloride (Page 4 of 4)

16 HOW SUPPLIED/STORAGE AND HANDLING

Terbinafine tablets USP, 250 mg are supplied as light pink with mottled surface, round, bi-convex, tablets debossed with “501” on one side and plain on the other side.

Bottles of 30 tablets………………… NDC 42043-410-03, with a child-resistant closure.

Bottles of 100 tablets………………… NDC 42043-410-01, with a child-resistant closure.

Store terbinafine tablets at 20° to 25°C (68° to 77 °F) [see USP Controlled Room Temperature]; in a tight container. Protect from light.

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-Approved Medication Guide.

Patients taking terbinafine tablets should receive the following information and instructions:

  • Advise patients to immediately report to their physician or get emergency help if they experience any of the following symptoms: hives, mouth sores, blistering and peeling of skin, swelling of face, lips, tongue, or throat, difficulty swallowing or breathing. Terbinafine tablets treatment should be discontinued.
  • Advise patients to immediately report to their physician any symptoms of persistent nausea, anorexia, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, or pale stools. Terbinafine tablets treatment should be discontinued.
  • Advise patients to report to their physician any signs of taste disturbance, smell disturbance and/or depressive symptoms, fever, skin eruption, lymph node enlargement, erythema, scaling, loss of pigment, and unusual photosensitivity that can result in a rash. Terbinafine tablets treatment should be discontinued.
  • Advise patients to minimize exposure to natural and artificial sunlight (tanning beds or UVA/B treatment) while using terbinafine tablets.
  • Advise patients that if they forget to take terbinafine tablets, to take their tablets as soon as they remember, unless it is less than 4 hours before the next dose is due.
  • Advise patients to call their physician if they take too many terbinafine tablets.
  • Advise patients to call their physician if they become pregnant during treatment with terbinafine tablets.

MEDICATION GUIDE

Terbinafine (ter-BIN-ah-fin) Tablets, USP

What is the most important information I should know about terbinafine tablets?

Terbinafine tablets may cause serious side effects, including:

  • Liver problems that can lead to the need for a liver transplant or death. This can happen in people who have liver problems and in people who have never had liver problems. Tell your doctor right away if you get any of these symptoms of liver problems:
  • nausea
  • poor appetite
  • tiredness
  • vomiting
  • upper right stomach-area (abdomen) pain
  • yellowing of your skin or eyes (jaundice)
  • dark (tea-colored) urine
  • pale or light colored stools

Your doctor should do a blood test to check you for liver problems before you start treatment with terbinafine tablets. Your doctor may also check you for liver problems during treatment, and tell you to stop taking terbinafine tablets if you develop liver problems.

What are terbinafine tablets?

Terbinafine tablets are a prescription medicine used to treat fungal infections of the fingernails and toenails (onychomycosis).

Your doctor should do tests to check you for fungal infection of your nails before you start terbinafine tablets.

It is not known if terbinafine tablets are safe and effective in children for the treatment of onychomycosis.

Who should not take terbinafine tablets?

Do not take terbinafine tablets if you:

  • have had liver disease for a long time (chronic) or have active liver disease.
  • have had a severe allergic reaction to terbinafine hydrochloride when taken by mouth.

What should I tell my doctor before taking terbinafine tablets?

Before taking terbinafine tablets, tell your doctor about all of your medical conditions, including if you:

  • have or had liver problems
  • have a weakened immune system (immunocompromised)
  • have lupus (an autoimmune disease)
  • are pregnant or plan to become pregnant. It is not known if terbinafine tablets may harm your unborn baby. Tell your doctor right away if you become pregnant during treatment with terbinafine tablets.
  • are breastfeeding or plan to breastfeed. Terbinafine hydrochloride passes into your breast milk and may harm your baby. Talk to your doctor about the best way to feed your baby if you take terbinafine tablets.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Terbinafine tablets may affect the way other medicines work and other medicines may affect how terbinafine tablets work.

How should I take terbinafine tablets?

  • Take terbinafine tablets exactly as your doctor tells you to take them.
  • Terbinafine hydrochloride comes as a tablet that you take by mouth.
  • Terbinafine tablets are usually taken:
  • 1 time each day for 6 weeks to treat fungal infections of your fingernail, or
  • 1 time each day for 12 weeks to treat fungal infections of your toenail
  • Terbinafine tablets can be taken with or without food.
  • If you miss a dose of terbinafine tablets, take it as soon as you remember. If it is less than 4 hours before your next dose, skip the missed dose. Just take the next dose at your regular time.

If you take too many terbinafine tablets call your doctor. You may have the following symptoms:

  • nausea
  • stomach-area (abdomen) pain
  • frequent urination
  • rash
  • headache
  • vomiting
  • dizziness

What should I avoid while taking terbinafine tablets?

  • Avoid sunlight. Terbinafine tablets can make your skin sensitive to the sun and the light from sunlamps and tanning beds. You can get a severe sunburn. Use sunscreen and wear a hat and clothes that cover your skin if you have to be in sunlight. Talk to your doctor if you get sunburn.

What are the possible side effects of terbinafine tablets?

Terbinafine tablets may cause serious side effects, including:

  • See “What is the most important information I should know about terbinafine tablets?”
  • Change in your sense of taste or loss of taste is common with terbinafine tablets, but can also be severe. This may improve within several weeks after you stop taking terbinafine tablets, but may last for a long time or may become permanent. Tell your doctor if you develop any of the following:
  • change in your sense of taste or loss of taste
  • poor appetite
  • weight loss
  • anxiousness

  • change in your mood or depressive symptoms. See the list of depressive symptoms below.
  • Change in your sense of smell or loss of smell may happen with terbinafine tablets. This may improve after you stop taking terbinafine tablets, but may last for a long time or may become permanent. Tell your doctor if you have a change in your sense of smell or loss of smell.
  • Depressive symptoms. Tell your doctor right away if you develop any of these signs or symptoms:
  • feel sad or worthless
  • change in sleep pattern
  • mood changes
  • loss of energy or interest in daily activities
  • restlessness
  • Low white blood cell count. Terbinafine tablets may decrease your white blood cell count, especially neutrophils. You may have a higher risk of getting an infection when your white blood cell count is low.
  • Serious skin or allergic reactions, which may include problems with some of your body organs. Tell your doctor right away or get emergency medical help if you get any of these symptoms:
  • skin rash
  • hives
  • sores in your mouth, or your skin blisters and peels
  • swelling of your face, eyes, lips, tongue or throat
  • trouble swallowing or breathing
  • fever
  • swollen lymph glands

Also tell your doctor about any new symptoms, such as cough, chest pain, fast heartbeat, or blood in your urine.

  • New or worsening lupus. Stop taking terbinafine tablets and tell your doctor if you get any of the following:
  • a skin rash that gets worse (progresses), is scaly, red, shows scarring, or loss of skin color
  • unusual sensitivity to the sun that can cause a rash
  • Blood clotting problems. When taking terbinafine tablets, you may develop a blood clotting problem, that can sometimes cause death. Tell your doctor, if you get any unexplained bleeding or bruising.

The most common side effects of terbinafine tablets include:

  • headache
  • diarrhea
  • rash
  • upset stomach
  • abnormal liver function tests
  • itching
  • nausea
  • stomach-area (abdomen) pain
  • gas

These are not all of the possible side effects of terbinafine tablets.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store terbinafine tablets?

  • Store terbinafine tablets at 20° to 25°C (68° to 77 °F).
  • Keep terbinafine tablets in a tightly closed container and keep out of the light.

Keep terbinafine tablets and all medicines out of the reach of children.

General information about the safe and effective use of terbinafine tablets

Medicines are sometimes prescribed for purposes other than those listed in Medication Guide. Do not use terbinafine tablets for a condition for which they were not prescribed. Do not give terbinafine tablets to other people, even if they have the same symptoms that you have. They may harm them.

You can ask your pharmacist or doctor for information about terbinafine tablets that is written for health professionals.

What are the ingredients in terbinafine tablets?

Active ingredient: terbinafine hydrochloride, USP

Inactive ingredients: colloidal silicon dioxide, ferric oxide, hypromellose, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate.

This Medication Guide has been approved by the U.S. Food and Drug Administration


Manufactured for: OrchidPharma, Inc.
Princeton, NJ 08540, USA


Manufactured by: Orchid Healthcare
(A Division of Orchid Pharma Ltd.)
Irungattukottai — 602 117, India


Revised: 3/2020

948026700

OrchidPharma

NDC 42043-410-03

Terbinafine Tablets, USP

250 mg

30 Tablets

Rx only

terbinafine-tablets--figure-2
(click image for full-size original)
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:42043-410
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TERBINAFINE HYDROCHLORIDE (TERBINAFINE) TERBINAFINE 250 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
SODIUM STARCH GLYCOLATE TYPE A POTATO
SILICON DIOXIDE
FERRIC OXIDE RED
MAGNESIUM STEARATE
HYPROMELLOSE 2910 (5 MPA.S)
Product Characteristics
Color pink (light pink) Score no score
Shape ROUND (round biconvex) Size 11mm
Flavor Imprint Code 501
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:42043-410-03 30 TABLET in 1 BOTTLE, PLASTIC None
2 NDC:42043-410-01 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078163 10/01/2020
Labeler — OrchidPharma Inc (809429207)
Registrant — Orchid Pharma Ltd (650133507)
Establishment
Name Address ID/FEI Operations
Orchid Helathcare (A Division of Orchid Pharma Limited) 650288850 analysis (42043-410), manufacture (42043-410), pack (42043-410), label (42043-410)

Revised: 01/2022 OrchidPharma Inc

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.